Pathological and clinical characteristics of large prostate cancers predominantly located in the transition zone
- 1 December 2002
- journal article
- research article
- Published by Springer Nature in Prostate Cancer and Prostatic Diseases
- Vol. 5 (4) , 279-284
- https://doi.org/10.1038/sj.pcan.4500602
Abstract
Prostate carcinomas located in the transition zone are suspected to behave differently from the more frequent peripheral zone cancers. In this study, large transition zone prostate cancers were investigated for pathological and clinical features. From 365 consecutive radical prostatectomy specimens, 73 cases were disclosed with tumours larger than 10 cm(3). Of these, 14 were predominantly (>70% tumour area) located in the transition zone. Pathological investigations included a complete histological work-up, immunohistochemistry for p53 and bcl-2, and interphase cytogenetics for chromosomes 7, 8, 17, and X. Despite large tumour volumes and high preoperative prostate specific antigen (PSA)-values, most tumours showed quite favourable pathological features. Only two of these patients suffered from a postoperative PSA-recurrence during a median follow-up of 50 months. For comparison, 36 cases that contained tumours predominantly located in the peripheral zone mostly displayed adverse prognostic signs and 68.8% of these patients suffered from postoperative PSA-recurrence. We conclude that the peculiar pathological and clinical characteristics of large prostate cancers in the transition zone might be important for prognostic considerations.Keywords
This publication has 15 references indexed in Scilit:
- AN ANALYSIS OF 148 CONSECUTIVE TRANSITION ZONE CANCERS: CLINICAL AND HISTOLOGICAL CHARACTERISTICSJournal of Urology, 2000
- PROSTATE CANCER IS HIGHLY PREDICTABLE: A PROGNOSTIC EQUATION BASED ON ALL MORPHOLOGICAL VARIABLES IN RADICAL PROSTATECTOMY SPECIMENSJournal of Urology, 2000
- Cell proliferation, apoptosis, oncogene, and tumor suppressor gene status in adenosis with comparison to benign prostatic hyperplasia, prostatic intraepithelial neoplasia, and cancerHuman Pathology, 1999
- Allelic losses at 8p, 10q, 11p, 13q, 16q, 17p, and 18q in prostatic carcinomas: The impact of zonal location, Gleason grade, and tumour multifocalityProstate Cancer and Prostatic Diseases, 1999
- Biological Determinants of Cancer Progression in Men With Prostate CancerJAMA, 1999
- LOCALLY RECURRENT PROSTATE TUMORS FOLLOWING EITHER RADIATION THERAPY OR RADICAL PROSTATECTOMY HAVE CHANGES IN KI-67 LABELING INDEX, P53 AND BCL-2 IMMUNOREACTIVITYJournal of Urology, 1998
- Assessment of the biologic markers p53, ki‐67, and apoptotic index as predictive indicators of prostate carcinoma recurrence after surgeryCancer, 1998
- NUMERICAL CHROMOSOMAL ABERRATIONS IN TRANSITION-ZONE CARCINOMAS OF THE PROSTATEJournal of Urology, 1997
- Elevated Levels of Apoptosis Regulator Proteins P53 and BCL-2 are Independent Prognostic Biomarkers in Surgically Treated Clinically Localized Prostate CancerJournal of Urology, 1996
- Zonal Distribution of Prostatic AdenocarcinomaThe American Journal of Surgical Pathology, 1988